 Steve Groshong
Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 15 | 2023 | 691 | 1.020 |
Why?
| | Lung | 25 | 2023 | 4103 | 0.560 |
Why?
| | Lung Diseases, Interstitial | 12 | 2017 | 660 | 0.550 |
Why?
| | Lung Diseases | 3 | 2023 | 783 | 0.390 |
Why?
| | Alveolitis, Extrinsic Allergic | 3 | 2023 | 93 | 0.390 |
Why?
| | Mucin-5B | 6 | 2018 | 234 | 0.390 |
Why?
| | Tomography, X-Ray Computed | 11 | 2023 | 2772 | 0.380 |
Why?
| | Biopsy | 9 | 2019 | 1081 | 0.380 |
Why?
| | Pulmonary Fibrosis | 6 | 2020 | 393 | 0.370 |
Why?
| | Fibroblasts | 6 | 2020 | 1023 | 0.290 |
Why?
| | Bleomycin | 3 | 2020 | 253 | 0.280 |
Why?
| | Interdisciplinary Communication | 1 | 2009 | 200 | 0.270 |
Why?
| | Bronchoscopy | 4 | 2018 | 227 | 0.240 |
Why?
| | Diagnosis, Differential | 9 | 2023 | 1507 | 0.230 |
Why?
| | Emergency Medical Technicians | 1 | 2006 | 43 | 0.230 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 427 | 0.210 |
Why?
| | Acute Lung Injury | 2 | 2022 | 301 | 0.210 |
Why?
| | Machine Learning | 3 | 2019 | 590 | 0.200 |
Why?
| | Cysts | 2 | 2023 | 112 | 0.200 |
Why?
| | Birt-Hogg-Dube Syndrome | 1 | 2023 | 8 | 0.200 |
Why?
| | Peritoneal Neoplasms | 1 | 2004 | 105 | 0.190 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2023 | 36 | 0.190 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2023 | 37 | 0.190 |
Why?
| | Teratoma | 1 | 2004 | 124 | 0.190 |
Why?
| | Apoptosis | 4 | 2018 | 2411 | 0.170 |
Why?
| | Research Report | 1 | 2022 | 86 | 0.170 |
Why?
| | Cough | 2 | 2015 | 123 | 0.170 |
Why?
| | Bronchial Diseases | 2 | 2012 | 38 | 0.160 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 22 | 0.160 |
Why?
| | Myofibroblasts | 2 | 2018 | 144 | 0.150 |
Why?
| | Middle Aged | 31 | 2021 | 36169 | 0.150 |
Why?
| | Glioma | 1 | 2004 | 429 | 0.150 |
Why?
| | Lung Neoplasms | 4 | 2018 | 2664 | 0.150 |
Why?
| | Biomarkers, Tumor | 4 | 2014 | 1321 | 0.150 |
Why?
| | Inflammation | 5 | 2022 | 2883 | 0.150 |
Why?
| | Phenotype | 5 | 2015 | 3157 | 0.150 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 475 | 0.140 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 8 | 0.140 |
Why?
| | Common Variable Immunodeficiency | 1 | 2018 | 25 | 0.140 |
Why?
| | Dihematoporphyrin Ether | 1 | 2018 | 2 | 0.140 |
Why?
| | Photochemotherapy | 1 | 2018 | 39 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 595 | 0.130 |
Why?
| | Photosensitizing Agents | 1 | 2018 | 41 | 0.130 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2009 | 97 | 0.130 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 443 | 0.130 |
Why?
| | Humans | 47 | 2023 | 145482 | 0.130 |
Why?
| | Complement C3 | 1 | 2018 | 192 | 0.130 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2594 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 368 | 0.120 |
Why?
| | HLA-DQ beta-Chains | 1 | 2016 | 58 | 0.120 |
Why?
| | fas Receptor | 2 | 2018 | 92 | 0.120 |
Why?
| | Aged | 20 | 2021 | 26117 | 0.120 |
Why?
| | Genetic Loci | 2 | 2016 | 260 | 0.110 |
Why?
| | HLA-DRB1 Chains | 1 | 2016 | 110 | 0.110 |
Why?
| | Case-Control Studies | 8 | 2018 | 3619 | 0.110 |
Why?
| | Genotype | 2 | 2018 | 1853 | 0.110 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 44 | 0.110 |
Why?
| | Genomics | 1 | 2021 | 834 | 0.110 |
Why?
| | Adenocarcinoma | 2 | 2018 | 923 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 49 | 0.100 |
Why?
| | Receptors, Bombesin | 1 | 2014 | 5 | 0.100 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1378 | 0.100 |
Why?
| | Epithelial Cells | 4 | 2020 | 1112 | 0.100 |
Why?
| | Female | 29 | 2021 | 78756 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.100 |
Why?
| | Male | 28 | 2021 | 72808 | 0.100 |
Why?
| | Carcinoma, Small Cell | 1 | 2014 | 172 | 0.100 |
Why?
| | Dyspnea | 1 | 2015 | 250 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 1188 | 0.090 |
Why?
| | Genetic Variation | 1 | 2018 | 988 | 0.090 |
Why?
| | Mucin 5AC | 1 | 2013 | 71 | 0.090 |
Why?
| | Collagen | 2 | 2012 | 453 | 0.090 |
Why?
| | Immunohistochemistry | 6 | 2018 | 1710 | 0.090 |
Why?
| | E2F1 Transcription Factor | 1 | 2012 | 68 | 0.090 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 63 | 0.090 |
Why?
| | Adult | 17 | 2023 | 40703 | 0.090 |
Why?
| | Mice | 11 | 2022 | 18338 | 0.090 |
Why?
| | Bronchi | 1 | 2013 | 263 | 0.090 |
Why?
| | Up-Regulation | 2 | 2013 | 848 | 0.090 |
Why?
| | Cilia | 1 | 2013 | 173 | 0.090 |
Why?
| | Trachea | 1 | 2013 | 258 | 0.090 |
Why?
| | Disease Models, Animal | 5 | 2018 | 4559 | 0.090 |
Why?
| | Asthma | 2 | 2015 | 1795 | 0.090 |
Why?
| | Lipopolysaccharides | 2 | 2012 | 855 | 0.080 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 59 | 0.080 |
Why?
| | Algorithms | 1 | 2019 | 1855 | 0.080 |
Why?
| | Animals | 14 | 2022 | 38141 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 2 | 2012 | 1177 | 0.080 |
Why?
| | Genetic Markers | 3 | 2021 | 334 | 0.080 |
Why?
| | Pulmonary Medicine | 1 | 2011 | 78 | 0.080 |
Why?
| | beta Carotene | 1 | 2010 | 20 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2146 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 275 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2021 | 2002 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2945 | 0.080 |
Why?
| | Pulmonary Alveoli | 2 | 2009 | 383 | 0.080 |
Why?
| | Coronavirus, Rat | 1 | 2009 | 1 | 0.080 |
Why?
| | Serum Amyloid A Protein | 1 | 2009 | 32 | 0.080 |
Why?
| | Virus Replication | 2 | 2009 | 527 | 0.070 |
Why?
| | Salivary Glands, Minor | 1 | 2009 | 10 | 0.070 |
Why?
| | Proteins | 1 | 2015 | 1020 | 0.070 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 19 | 0.070 |
Why?
| | Sjogren's Syndrome | 1 | 2009 | 37 | 0.070 |
Why?
| | Gammaherpesvirinae | 1 | 2009 | 45 | 0.070 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 57 | 0.070 |
Why?
| | Actinomycosis | 1 | 2008 | 5 | 0.070 |
Why?
| | Immunity, Innate | 2 | 2012 | 846 | 0.070 |
Why?
| | Hemorrhage | 1 | 2014 | 826 | 0.070 |
Why?
| | Toll-Like Receptor 2 | 1 | 2009 | 127 | 0.070 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1769 | 0.070 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2009 | 63 | 0.070 |
Why?
| | Societies, Medical | 2 | 2011 | 898 | 0.070 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2009 | 131 | 0.070 |
Why?
| | Scleroderma, Limited | 1 | 2008 | 5 | 0.070 |
Why?
| | Disease Progression | 4 | 2023 | 2862 | 0.070 |
Why?
| | Signal Transduction | 2 | 2020 | 5202 | 0.070 |
Why?
| | Prospective Studies | 6 | 2021 | 8039 | 0.070 |
Why?
| | Herpesviridae Infections | 1 | 2009 | 149 | 0.070 |
Why?
| | Hypertension, Pulmonary | 2 | 2012 | 1957 | 0.070 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 5 | 0.070 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2007 | 47 | 0.060 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 29 | 0.060 |
Why?
| | Foreign Bodies | 1 | 2008 | 110 | 0.060 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 36 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 441 | 0.060 |
Why?
| | Autoantibodies | 2 | 2012 | 1512 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3424 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 342 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2020 | 4127 | 0.060 |
Why?
| | Pneumonia | 2 | 2009 | 632 | 0.060 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 126 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1127 | 0.060 |
Why?
| | Missouri | 1 | 2006 | 66 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2010 | 580 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2009 | 782 | 0.060 |
Why?
| | Ambulances | 1 | 2006 | 54 | 0.060 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 1247 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2018 | 3125 | 0.050 |
Why?
| | Aged, 80 and over | 5 | 2021 | 8320 | 0.050 |
Why?
| | Gene Expression | 3 | 2017 | 1478 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1212 | 0.050 |
Why?
| | Coronavirus Infections | 1 | 2009 | 383 | 0.050 |
Why?
| | Retinoblastoma Protein | 1 | 2004 | 61 | 0.050 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 72 | 0.050 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 42 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2009 | 878 | 0.050 |
Why?
| | Biopsy, Needle | 2 | 2018 | 185 | 0.050 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 249 | 0.050 |
Why?
| | Hysterectomy | 1 | 2004 | 137 | 0.050 |
Why?
| | Smoking | 1 | 2010 | 1468 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2023 | 2060 | 0.050 |
Why?
| | Gene Frequency | 2 | 2015 | 483 | 0.050 |
Why?
| | Vital Capacity | 1 | 2023 | 292 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 2129 | 0.040 |
Why?
| | Cohort Studies | 4 | 2017 | 5992 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 208 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 269 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2355 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 751 | 0.040 |
Why?
| | Interleukin-10 | 2 | 2014 | 313 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 551 | 0.040 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 543 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2004 | 643 | 0.040 |
Why?
| | Macrophages, Alveolar | 2 | 2014 | 368 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2014 | 974 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2006 | 697 | 0.030 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 71 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 82 | 0.030 |
Why?
| | Chronic Disease | 2 | 2018 | 1816 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 75 | 0.030 |
Why?
| | Retrospective Studies | 6 | 2014 | 17262 | 0.030 |
Why?
| | Rats | 3 | 2011 | 5581 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 797 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 438 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 772 | 0.030 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2016 | 46 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 616 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 632 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2020 | 355 | 0.030 |
Why?
| | Pneumonectomy | 1 | 2018 | 167 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 5 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 5 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 16 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 29 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1707 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 28 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 61 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5989 | 0.030 |
Why?
| | NF-kappa B | 2 | 2009 | 660 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 619 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2009 | 1156 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 64 | 0.030 |
Why?
| | Auscultation | 1 | 2015 | 4 | 0.030 |
Why?
| | Herpesviridae | 1 | 2015 | 22 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 88 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2373 | 0.030 |
Why?
| | Hemosiderin | 1 | 2014 | 2 | 0.030 |
Why?
| | Bleeding Time | 1 | 2014 | 5 | 0.030 |
Why?
| | Cell Line | 2 | 2011 | 2823 | 0.030 |
Why?
| | Neutrophils | 2 | 2011 | 1124 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 103 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1706 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 9 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2499 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 172 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 64 | 0.030 |
Why?
| | Fibrin | 1 | 2014 | 84 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 396 | 0.020 |
Why?
| | Neoplasms | 1 | 2009 | 2897 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 294 | 0.020 |
Why?
| | Clone Cells | 1 | 2013 | 264 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2013 | 41 | 0.020 |
Why?
| | Keratins | 1 | 2013 | 171 | 0.020 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 99 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 13 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.020 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 27 | 0.020 |
Why?
| | DNA, Viral | 1 | 2015 | 357 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 456 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 2130 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 84 | 0.020 |
Why?
| | Young Adult | 3 | 2017 | 14192 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 616 | 0.020 |
Why?
| | Alveolar Epithelial Cells | 1 | 2013 | 120 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2023 | 11826 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2012 | 63 | 0.020 |
Why?
| | Regeneration | 1 | 2013 | 198 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 132 | 0.020 |
Why?
| | Blood Coagulation Factors | 1 | 2012 | 72 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 407 | 0.020 |
Why?
| | Pulmonary Eosinophilia | 1 | 2011 | 27 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| | Connective Tissue Diseases | 1 | 2012 | 85 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 387 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 138 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 284 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 273 | 0.020 |
Why?
| | Cocarcinogenesis | 1 | 2010 | 13 | 0.020 |
Why?
| | Cytochromes | 1 | 2010 | 10 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2010 | 42 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 322 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2010 | 32 | 0.020 |
Why?
| | Endotoxins | 1 | 2011 | 218 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1332 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 852 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2010 | 63 | 0.020 |
Why?
| | Spleen | 1 | 2012 | 511 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 550 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 831 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2010 | 117 | 0.020 |
Why?
| | Purpura | 1 | 2009 | 18 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 639 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 41 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1304 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 80 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2011 | 247 | 0.020 |
Why?
| | Granuloma | 1 | 2009 | 97 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 268 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1313 | 0.020 |
Why?
| | Elastin | 1 | 2009 | 78 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 236 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2009 | 104 | 0.020 |
Why?
| | Myoblasts | 1 | 2009 | 83 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 411 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2008 | 16 | 0.020 |
Why?
| | Testicular Neoplasms | 1 | 2009 | 111 | 0.020 |
Why?
| | Thrombosis | 1 | 2012 | 401 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 518 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 306 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 295 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 153 | 0.020 |
Why?
| | Phagocytosis | 1 | 2009 | 297 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 22485 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 839 | 0.020 |
Why?
| | Lymphocytes | 1 | 2009 | 379 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 430 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 456 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1374 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 925 | 0.020 |
Why?
| | Photomicrography | 1 | 2006 | 8 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 1038 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 162 | 0.020 |
Why?
| | RNA | 1 | 2013 | 929 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 106 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 325 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1261 | 0.020 |
Why?
| | Rare Diseases | 1 | 2007 | 116 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2007 | 149 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1049 | 0.010 |
Why?
| | MicroRNAs | 1 | 2012 | 689 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2013 | 2045 | 0.010 |
Why?
| | Risk Factors | 1 | 2020 | 10874 | 0.010 |
Why?
| | Base Sequence | 1 | 2009 | 2180 | 0.010 |
Why?
| | Acute Disease | 1 | 2008 | 1040 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2009 | 772 | 0.010 |
Why?
| | Lung Transplantation | 1 | 2008 | 330 | 0.010 |
Why?
| | Colonoscopy | 1 | 2007 | 262 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1047 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2004 | 27 | 0.010 |
Why?
| | Weight Loss | 1 | 2009 | 839 | 0.010 |
Why?
| | Liver | 1 | 2012 | 1895 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1755 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2950 | 0.010 |
Why?
| | Biomarkers | 1 | 2015 | 4283 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 743 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 780 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 2054 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 675 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2820 | 0.010 |
Why?
| | Mutation | 1 | 2011 | 4093 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 5425 | 0.010 |
Why?
| | United States | 1 | 2011 | 16114 | 0.010 |
Why?
|
|
Groshong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|